Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. The Manila Times
Risk factors, survival analysis, and nomograms for high-grade endometrial stromal sarcoma patients with distant metastasis: A population-based study (2010-2019) - Frontiers
Risk factors, survival analysis, and nomograms for high-grade endometrial stromal sarcoma patients with distant metastasis: A population-based study (2010-2019) Frontiers